Biochip News: Breaking Biochip News, Comments and Articles. - Page: 5

Farewell to Bioinformatics

Here are some angry views that I don't necessarily endorse, but I can't say that they're completely wrong, either. A programmer bids an angry farewell to the bioinformatics world: Bioinformatics is an attempt to make molecular biology relevant to re...

MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities

Saint Louis, MO, January 28, 2013 --(PR.com)-- MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising projects in Agriculture and Pharmaceutical areas involv...

SQI Diagnostics and Algorithme Pharma to Develop Multiplex Heparin Immunogenicity Assay

SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), and Algorithme Pharma (“Algorithme”) today announced that they are using SQI’s Ig_PlexTM multiplexing technology to develop a multiplex proof of concept assa...

Chromosomal Microarray Evaluated for Prenatal Diagnosis

Chromosomal microarray analysis has been evaluated and compared to karyotyping for routine prenatal diagnosis.

SurModics to Webcast First Quarter 2013 Earnings Conference Call on January 30

SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its first quarter 2013 conference call on Wednesday, January 30, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afterno...

Microarray Analysis in Stillbirth

Microarray analysis can help identify genetic causes of stillbirth, according to a large study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Lineagen Announces New Study Demonstrating Two-Fold Increase in Detection Rate of Validated Genetic Variants in Individuals with Autism Spectrum Disorders

SALT LAKE CITY, Jan. 15, 2013 /PRNewswire/ -- Lineagen, Inc. today announced publication of the results of a 9,000-person genetic study that demonstrates an approximately 100% increase in the detection rate of genetic markers now validated as being associated with autism spectrum disorders (ASDs).  The study, one of the largest genetic validation studies in autism, was designed to confir...

NovAliX, Kyowa in discovery deal

NovAliX S.A.S. (Illkirch, France) partnered with Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) to use NovaAliX's Graffinity fragment-based screening technology to discover and develop small molecule compounds against undisclosed protein-protein interaction...

Akonni Biosystems Expands Family of TruTip Extraction Products for Hamilton Microlab STAR Line of Liquid Handling Workstations

Akonni Biosystems today announced it has extended its family of “smart-tip” extraction products for rapidly purifying human genomic deoxyribonucleic acid (gDNA) on the Hamilton Microlab® STAR™ line of robotic liquid handling workstations. The first product in the family of gDNA kits provides laboratory technicians with the ability to process up to 3...

Affymetrix microarrays news

New technique comprehensively generates three-dimensional maps of gene expression in the brain

A research team led by Yuko Okamura-Oho and Hideo Yokota of the RIKEN Advanced Science Institute, Wako, has developed a novel technique for three-dimensional (3D) mapping of gene expression patterns onto brain structures. The technique, known as tran...

Verinata Health Publishes Proof-of-Concept Data Showing Non-Invasive Fetal Karyotype Equivalent to Invasive Procedures

REDWOOD CITY, Calif., Jan. 10, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its proprietary prenatal technology can detect fetal subchromosomal abnormalities non-invasively from maternal blood. These proof-of-concept data show that Verinata's proprietary approach together with deep massively parallel sequencing (M...

Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis

PHILADELPHIA and REHOVOT, Israel, Jan. 9, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a study assessing the differences between cancer of unknown primary (CUP) and metastatic solid tumors of known primary metastases (KPM) by profiling microRNA expression were recently published i...

Biochip technology uses tiny whirlpools to corral microbes

Affymetrix previews 4Q12 figures, reducing headcount

Affymetrix Inc. (NASDAQ:AFFX) said it expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience business segment. The Street is expecting 4Q12 revenues of $84.4 million and a non-GAAP loss per share for the...

Akonni Pre-Clinical Results on Rapid, Low-cost Array Moves Company Closer to Commercialization for its Infectious Disease Test Portfolio

Akonni Biosystems announced results today from three pre-clinical studies that contribute to the body of clinical evidence that verifies the efficacy of Akonni’s TruDiagnosis molecular diagnostics (MDx) platform. Akonni TruArray® Tests are designed to fulfill market needs for mid-multiplex molecular diagnostics (tens to hundreds of molecular markers) de...

New biochip technology uses tiny whirlpools to corral microbes

(Purdue University) Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and resea...

Roche: Illumina acquisition 'off the table'

Illumina Inc. (NASDAQ:ILMN) fell $3.86 to $50.90 on Monday after Roche (SIX:ROG; OTCQX:RHHBY) said a deal to acquire the sequencing and microarray company is "off the table." The pharma declined to provide further details. In April 2012, Illumina's b...

OriGene Publishes Landmark Paper on Revolutionary Proteome Platform for Antibody Specificity Test

ROCKVILLE, Md., Jan. 7, 2013 /PRNewswire/ -- OriGene Technologies, Inc. ("OriGene"), one of the industry leaders in producing genome wide products for research and diagnostic applications, has brought the antibody field one step closer to identifying and developing ultra-specific monoclonal antibodies.  Specificity of antibodies for research or clinical applications is of cri...

Reuse of public genome-wide gene expression data

A wealth of microarray gene expression data and a growing volume of RNA sequencing data are now available in public databases. The authors look at how these data are being used and discuss considerations for how such data should be analysed and depos...

Microarray Detects Viral Antibodies and Quantifies C-Reactive Protein

An immobilization method for an immunoassay-based microarray for a serologic diagnostic method has been combined with quantitative C-reactive...

SurModics Appoints Andy LaFrence as Chief Financial Officer

SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced the appointment of Andy LaFrence as the company’s Vice President of Finance and Chief Financial Officer, effective February 12, 2013. He will lead all of the financial activities of SurModics, includ...

Illumina gains on rumors of new Roche bid

Illumina Inc. (NASDAQ:ILMN) jumped $4.02 (8%) to $56.19 on Thursday on rumors that Roche (SIX:ROG; OTCQX:RHHBY) made another bid to acquire the sequencing and microarray company for $66 per share, or about $8.1 billion. The price would be a 48% premi...

23andMe Presents Top Ten Most Interesting Genetic Findings of 2012

MOUNTAIN VIEW, Calif., Dec. 20, 2012 /PRNewswire/ -- 23andMe has released its third annual list of the ten most interesting and significant genetic findings in 2012 as part of the company's ongoing efforts to understand the role of genetics in personal health and human development. "It's a very exciting time in the world of genetics.  Technology improvements and big datasets are making...

Chinese CRO looks to foray into molecular diagnostics arena

Shanghai Biochip, a contract research organization, reportedly is making moves into the molecular diagnostics segment in Chin -More-